List view / Grid view



AmpliPhi Biosciences announce financial results Q2 2015

14 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review

Biotechnology company, AmpliPhi Biosciences Corporation, released financial results for the second quarter 2015 and operational highlights. AmpliPhi, one of the leaders in the development of bacteriophage-based antibacterial therapies to treat antibiotic-resistant infections, has reported strong overall performance in overall liquidity and balance sheet strength thanks to a $13 million investment…

Send this to a friend